摘要
目的评价疏血通注射液治疗缺血性脑卒中的疗效。方法将137例缺血性脑卒中患者分为两组,治疗组78例,对照组59例,均予阿司匹林、银杏叶注射液及基础治疗,治疗组加用疏血通8mL静脉滴注,1次/d,分别于治疗前及治疗后第7,14,21天时对患者进行欧洲卒中量表(ESS)评分、日常生活活动能力评定量表(ADL)及常规检查。结果治疗后第14,21天时,两组ESS及ADL评分有显著差异(P<0.05)。结论疏血通能明显改善缺血性脑卒中的预后,且不增加缺血性卒中后出血的风险。
Objective To explore the efficacy of Shuxuetong injection on cerebral arterial thrombosis. Methods 137 patients with cerebral arterial thrombosis were randomly divided into the therapeutic group （group A, n=78）and the control group （group B, n=59）. Two groups were used aspirin,Ginkgo biloba injection and basic treatment. The group A were additionally used Shuxuetong injection 8 mL, i. v., q. d.,for 21 d. Before treatment, and 7, 14, 21 d after treatment, european stroke scale （EES）, activity of daily living （ADL）, and routine examination were performed. Results On 14, 21 d after treatment, the values of EES and ADL existed the difference between two groups （P 〈 0. 05）. Conclusion Shuxuetong injection can improve the deficiency of the neurologic function in the patients with cerebral arterial thrombosis, without hemorrhagic risk.
出处
《中国药业》
CAS
2007年第11期40-41,共2页
China Pharmaceuticals
关键词
疏血通
注射液
缺血性脑卒中
疗效
Shuxuetong
injection
cerebral arterial thrombosis
efficacy
